Nonadherence to prescribed medication was detected in 55% of patients with apparent treatment-resistant hypertension and was independently associated with younger age, female sex, and pill burden.
Observational (n=300)
Yes
What factors are associated with nonadherence to antihypertensive medications in patients with apparent treatment-resistant hypertension?
In patients with apparent treatment-resistant hypertension, nonadherence is highly prevalent (55%) and strongly associated with higher pill burden, highlighting the need to consider medication burden in this population.
Objective: Nonadherence to medication is present in at least 50% of patients with apparent treatment-resistant hypertension. We examined the factors associated with nonadherence as detected by a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based urine antihypertensive drug assay. Methods: All urine antihypertensive test results, carried out for uncontrolled hypertension (BP persistently >140/90 mmHg) between January 2015 and December 2016 at a single toxicology laboratory were analysed. Drugs detected were compared with the antihypertensive drugs prescribed. Patients were classified as adherent (all drugs detected), partially nonadherent (at least one prescribed drug detected) or completely nonadherent (no drugs detected). Demographic and clinical parameters were compared between the adherent and nonadherent groups. Binary logistic regression analysis was performed to determine association between nonadherence and demographic and clinical factors. Results: Data on 300 patients from nine hypertension centres across the United Kingdom were analysed. The median age was 59 years, 47% women, 71% Caucasian, median clinic BP was 176/95 mmHg and the median number of antihypertensive drugs prescribed was four. One hundred and sixty-six (55%) were nonadherent to prescribed medication with 20% of these being completely nonadherent. Nonadherence to antihypertensive medication was independently associated with younger age, female sex, number of antihypertensive drugs prescribed, total number of all medications prescribed (total pill burden) and prescription of a calcium channel blocker. Conclusion: This LC-MS/MS urine analysis-based study suggests the majority of patients with apparent treatment-resistant hypertension are nonadherent to prescribed treatment. Factors that are associated with nonadherence, particularly pill burden, should be taken into account while treating these patients.
Lawson et al. (Fri,) conducted a observational in Apparent treatment-resistant hypertension (n=300). Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based urine antihypertensive drug assay was evaluated on Nonadherence to prescribed medication. Nonadherence to prescribed medication was detected in 55% of patients with apparent treatment-resistant hypertension and was independently associated with younger age, female sex, and pill burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: